Search results
Results from the Health.Zone Content Network
Not a lot of data exists about how HHC affects your body. But it is a form of THC, and those short-term effects are well-known. THC can: Alter your senses, including your sense of time. Change ...
Hexahydrocannabinol ( HHC) is a hydrogenated derivative of tetrahydrocannabinol (THC). It is a naturally occurring phytocannabinoid that has rarely been identified as a trace component in Cannabis sativa, [1] [2] but can also be produced synthetically by acid cyclization and hydrogenation of tetrahydrocannabinol.
Delta-8 vs. HHC Hexahydrocannabinol (HHC) is THC that’s gone through a chemical process called hydrogenation. Like delta-8, it's made from hemp, and you can find it in a lot of products, from ...
Harlem Hospital Center. / 40.814232; -73.940189. Harlem Hospital Center, branded as NYC Health + Hospitals/Harlem, is a 272-bed, public teaching hospital affiliated with Columbia University. [1] It is located at 506 Lenox Avenue in Harlem, Manhattan, New York City and was founded on April 18, 1887.
Hexahydrocannabiphorol ( HHCP, sometimes mistakenly referred to as hexahydroxycannabiphorol) is a semi-synthetic cannabinoid derivative which has been marketed since around 2021. [1] [2] It is believed to be made from the hydrogenation of tetrahydrocannabiphorol (THCP). THCP is only reported as a trace component of cannabis in 2019. [3]
dry mouth. increased heart rate. low blood pressure. memory loss. red eyes. slower reaction times. tiredness. Because of the lack of research on HHC, we don’t know whether it can produce some or ...
NYC Health + Hospitals, officially the New York City Health and Hospitals Corporation ( HHC ), operates the public hospitals and clinics in New York City as a public benefit corporation. HHC was created in 1969 by the New York State Legislature as a public benefit corporation. [1] It is similar to a municipal agency, but has a board of directors .
Hexahydrocannabivarin ( HHCV, HHC-V) is a semi-synthetic cannabinoid derivative, the hydrogenated derivative of tetrahydrocannabivarin (THCV). It was first synthesised by Roger Adams in 1942 and produces only weak cannabinoid-like effects in animals. [1] More recently it has been sold as an ingredient in grey-market cannabinoid products.